-Kimberly K Leslie Researcher Activity Profile

Research Author Detailed Information 

Kimberly K Leslie Publication Rate By Year

Kimberly K Leslie has published 1 paper(s) in 2002, 1 paper(s) in 2004, 5 paper(s) in 2007, for a total of 7 research publications in total.

Kimberly K Kk Leslie Author Information

LAST NAME: leslie

FIRST NAME: Kimberly K

INITIALS: kk

AFFILIATION:

Papers

Kimberly K Leslie's Publication Record

1. Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancer. Year Published: 2007
The Reproductive Molecular Biology Laboratory, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The University of New Mexico Health Science Center, Albuquerque, NM 87131, USA.
2. Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cells. Year Published: 2007
Obstetrics and Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Cancer Research and Treatment Center, The University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
3. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study. Year Published: 2007
Department of Pathology, The University of Colorado Health Sciences Center, Denver, CO 80262, United States.
4. Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy. Year Published: 2007
Department of Obstetrics and Gynecology, Division of Maternal and Fetal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
5. Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-up. Year Published: 2007
Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque, NM, USA.
6. Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2. Year Published: 2004
Reproductive Molecular Biology Laboratory, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of New Mexico Health Sciences Center, MSC 10 5580, 4200 East 9th Street, Albuquerque, NM 87131, USA.
7. A randomized controlled trial of interleukin-1 receptor antagonist in a rabbit model of ascending infection in pregnancy. Year Published: 2002
Department of Obstetrics and Gynecology, Kaiser Permanente, Denver, CO 80205, USA.